Chikungunya Vaccine
Chikungunya Vaccine is a preventive vaccine designed to protect against chikungunya virus infection, a mosquito-borne disease that can cause fever, severe joint pain, muscle pain and rash. Available vaccine types include virus-like particle vaccines and live-attenuated vaccines, with approved products and eligibility varying by country. The vaccine stimulates the immune system to develop an immune response against the chikungunya virus. Depending on the product, it is administered as a single intramuscular injection under healthcare professional supervision. Common side effects may include injection-site pain, headache, fatigue and muscle pain. Important precautions vary by vaccine type and may include pregnancy, immune-system disorders, severe allergies and other underlying medical conditions. Vaccination decisions should follow current local regulatory guidance and individual medical assessment.
Chikungunya Vaccine was historically used as a respiratory medicine for the symptomatic management of certain respiratory conditions. Its former uses included:
<div class="container"> <h1>Chikungunya Vaccine</h1> <p> The chikungunya vaccine helps protect against chikungunya, a viral disease spread by infected mosquitoes. </p> <h2>Uses</h2> <ul> <li>Helps prevent chikungunya disease.</li> <li>May be recommended for certain travellers visiting areas with chikungunya outbreaks.</li> <li>May be considered for laboratory workers at risk of exposure to the virus.</li> </ul> <h2>Common Symptoms of Chikungunya</h2> <ul> <li>High fever</li> <li>Severe joint pain</li> <li>Muscle pain</li> <li>Headache and rash</li> </ul> <h2>Important Information</h2> <div class="note"> The vaccine does not treat an existing infection. Vaccine eligibility and availability depend on local regulatory approval and individual health factors. Consult a healthcare professional before vaccination. </div> <h2>Prevention</h2> <ul> <li>Use mosquito repellent.</li> <li>Wear long-sleeved clothing.</li> <li>Remove stagnant water around your home.</li> </ul> </div> is okay
<div class="container"> <h1>Chikungunya Vaccine</h1> <h2>Contraindications and Precautions</h2> <ul> <li> <strong>Severe allergy:</strong> A history of anaphylaxis to a previous dose or any component of the specific vaccine. </li> <li> <strong>Pregnancy:</strong> Live-attenuated chikungunya vaccines are generally contraindicated during pregnancy. </li> <li> <strong>Weakened immune system:</strong> Live-attenuated vaccines may be contraindicated in people with significant immunosuppression. </li> <li> <strong>Acute illness:</strong> Vaccination may need to be postponed during a significant acute illness or fever. </li> <li> <strong>Older adults:</strong> People aged 65 years or older require particular caution with certain live chikungunya vaccines. </li> </ul> <div class="warning"> <strong>Important:</strong> Contraindications vary by vaccine type and product. Pregnancy, immune suppression, age, and acute illness must be assessed according to the specific vaccine's approved prescribing information. </div> <p class="footer"> This information is for educational purposes only. Consult a qualified healthcare professional before vaccination. </p> </div>
<h2>Where to Get Information</h2> <ul> <li>Consult a qualified healthcare professional.</li> <li>Check the Central Drugs Standard Control Organisation (CDSCO) for current vaccine approvals.</li> <li>Ask about availability and eligibility in your country if you are travelling abroad.</li> </ul> <h2>Prevention</h2> <ul> <li>Use mosquito repellent.</li> <li>Wear long-sleeved clothing.</li> <li>Remove stagnant water to prevent mosquito breeding.</li> </ul> <div class="note"> <strong>Important:</strong> Vaccine availability and eligibility depend on regulatory approval. Do not assume that a vaccine approved in another country is available in India. </div> <p> Official information: <a href="https://ncvbdc.mohfw.gov.in/" target="_blank" rel="noopener noreferrer"> National Centre for Vector Borne Diseases Control </a> </p>
<h3>1. Route of Administration</h3> <p> The route depends on the vaccine product. For example, IXCHIQ is administered as a single intramuscular injection, while VIMKUNYA is administered as a single intramuscular injection. </p> <h3>2. Dose and Schedule</h3> <ul> <li>Some approved vaccines use a single-dose schedule.</li> <li>Age eligibility depends on the specific vaccine and the country's regulatory approval.</li> <li>Follow the product's official prescribing information.</li> </ul> <h3>3. Administration Setting</h3> <p> Vaccination should be performed by a qualified healthcare professional in an appropriate healthcare setting. </p> <h3>4. Storage and Handling</h3> <p> Storage temperature, preparation, and handling must follow the manufacturer's instructions for the specific product. </p>
The import of medicines into India is regulated by the Central Drugs Standard Control Organisation (CDSCO) under the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. The regulatory requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished formulation, or an unapproved medicine intended for an individual patient's treatment.
Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Chikungunya Vaccine, subject to confirmation of its current regulatory status and eligibility for import into India.
The export of Chikungunya Vaccine from India is subject to applicable requirements under the Drugs and Cosmetics Act, 1940, the Drugs and Cosmetics Rules, 1945, and relevant export, customs, and destination-country regulations. Documentation requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished pharmaceutical formulation, or a medicine intended for a specific market. Export eligibility and destination-country requirements must be verified before shipment.
Primeera Healthcare Private Limited can provide pharmaceutical export documentation assistance, regulatory coordination, and shipping support for Chikungunya Vaccine, subject to confirmation of its export eligibility under applicable Indian regulations and the import requirements of the destination country.
If you have any questions or need any help, contact our Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
All Trademarks and Brands that appear on the website belong to their respective owners. Primeera Healthcare does not lay any claim on them; we only provide information.
